4basebio PLC (88Q.DE)
EUR 14.6
(0.0%)
EUR 14.6
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -7.66 Million GBP | -48.83% |
| 2022 | -5.15 Million GBP | -59.2% |
| 2021 | -3.23 Million GBP | -349.93% |
| 2020 | -719 Thousand GBP | -69.98% |
| 2019 | -423 Thousand GBP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -6.76 Million EUR | 0.0% |
| 2023 Q4 | -4.74 Million EUR | -14.58% |
| 2023 FY | -7.66 Million GBP | -48.83% |
| 2023 Q2 | -4.13 Million EUR | -34.6% |
| 2022 Q4 | -3.07 Million EUR | -8.91% |
| 2022 FY | -5.15 Million GBP | -59.2% |
| 2022 Q2 | -2.82 Million EUR | -49.71% |
| 2021 Q2 | -1.92 Million EUR | -409.01% |
| 2021 FY | -3.23 Million GBP | -349.93% |
| 2021 Q4 | -1.88 Million EUR | 1.93% |
| 2020 Q2 | -419.14 Thousand EUR | 0.0% |
| 2020 FY | -719 Thousand GBP | -69.98% |
| 2020 Q4 | -377.61 Thousand EUR | 9.91% |
| 2019 FY | -423 Thousand GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| BioNTech SE | 930.3 Million EUR | 100.824% |
| CureVac N.V. | -260.16 Million EUR | 97.054% |
| Biotest Aktiengesellschaft | 127 Million EUR | 106.035% |
| Biotest Aktiengesellschaft | 127 Million EUR | 106.035% |
| BRAIN Biotech AG | -8.27 Million EUR | 7.416% |
| Formycon AG | 75.79 Million EUR | 110.113% |
| Heidelberg Pharma AG | -20.34 Million EUR | 62.328% |
| Medigene AG | -16.17 Million EUR | 52.618% |